omni
aaps
Will There Be a Brexit Boom?
Will There Be a Brexit Boom?
While some analysts have warned that U.K.-based pharmaceutical companies may lose access to European Union markets once the country falls out of the bloc’s system and loses access to central marketing authorization for new drugs, such dangers are...
Complicated vs Complex Challenges in Pharma
Complicated vs Complex Challenges in Pharma
The pace, scope, and variety of challenges we face as executives in Pharma are both invigorating and overwhelming. They span macro trends such as personalized medicine, real-world-evidence (RWE), onerous regulatory pressures, collaborative R&D and Digi...
How to Stop Drug Price Gouging
How to Stop Drug Price Gouging
One of Donald Trump's few universally welcomed campaign promises was to do something about the prices of pharmaceutical drugs.
USDA Considering Changes in Biotechnology Regulations
USDA Considering Changes in Biotechnology Regulations
USDA is seeking public comment on whether the agency should draw up new rules to regulate biotechnology products. This comes after heavy criticism for not conducting environmental assessments on the potential effects of biotech crops. The agency is als...
WHO Suspends Tuberculosis Drugs From Major Indian Supplier
WHO Suspends Tuberculosis Drugs From Major Indian Supplier
The World Health Organization (WHO) reportedly suspended its approval of all tuberculosis products made at India’s Svizera Labs citing unreliable manufacturing standards and quality management. The company is one of the largest suppliers of gener...